Tart Cherry Supplementation & Gut Microbiome and Inflammation
The Effects Supplementation of Tart Cherry or Placebo on the Gut Microbiome, Inflammation, Oxidative Stress, and Health-related Outcomes.
1 other identifier
interventional
70
1 country
1
Brief Summary
There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (\< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2019
CompletedFirst Submitted
Initial submission to the registry
June 30, 2020
CompletedFirst Posted
Study publicly available on registry
July 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedSeptember 9, 2021
September 1, 2021
7 months
June 30, 2020
September 8, 2021
Conditions
Outcome Measures
Primary Outcomes (9)
Changes in inflammation measured via tumor necrosis factor alpha (pg/mL)
baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in inflammation measured via erythrocyte sedimentation rate (mm/hour)
baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in inflammation measured via c-reactive protein (mg/L) and uric acid (mg/dL).
baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in glucose regulation assessed via plasma glucose (mg/dL)
baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in glucose regulation assessed via insulin (mIU/L)
baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in glucose regulation assessed via glycated albumin (%).
baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in sleep quantity (hours and minutes) assessed via daily survey.
daily for 30 days
Changes in sleep quality measured via 100mm visual analogue scale.
daily for 30 days
Changes in gut microbiome bacterial counts
baseline, 14 days, and 30 days post supplementation.
Study Arms (4)
Tart cherry juice concentrate
EXPERIMENTALtart cherry juice
Freeze dried tart cherry powder
EXPERIMENTALtart cherry capsules
Juice placebo
EXPERIMENTALkool-aid
Capsule placebo
EXPERIMENTALmaltodextrin
Interventions
Two 8oz bottles of tart cherry juice concentrate daily for 30 days
Two freeze dried tart cherry powder capsules daily for 30 days
Eligibility Criteria
You may qualify if:
- years old
- participate in 150 minutes of exercise per week
- non-smoker
- have no known allergy to cherries or cherry juice
- are not taking food supplements (turmeric/curcumin, cherry products, greens, etc.). -You must have access to the internet and be willing to record your food intake, physical activity and sleep quality/duration during the study.
You may not qualify if:
- not 18-55 years old.
- have quit smoking less than one year ago.
- have been diagnosed with a metabolic disorder such as diabetes, thyroid disorder, or high cholesterol.
- are currently being treated for arthritis or an inflammatory condition, such as arthritis, gout, lupus or Sjogren's syndrome.
- are currently being treated for cardiovascular disease, high blood pressure, fibromyalgia, or irritable bowel syndrome.
- are pregnant.
- regularly consume cherries or are allergic to cherries.
- currently use anti-inflammatory medications.
- have used corticosteroids in the last two months.
- are not willing to follow a low polyphenol diet.
- are not willing to have blood drawn on 4 occasions.
- are not willing to provide a stool sample on 3 occasions.
- do not have access to the internet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio Universitylead
Study Sites (1)
Ohio University Exercise Physiology Lab
Athens, Ohio, 45701, United States
Related Publications (1)
Hillman AR, Chrismas BCR. Thirty Days of Montmorency Tart Cherry Supplementation Has No Effect on Gut Microbiome Composition, Inflammation, or Glycemic Control in Healthy Adults. Front Nutr. 2021 Sep 16;8:733057. doi: 10.3389/fnut.2021.733057. eCollection 2021.
PMID: 34604282DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 30, 2020
First Posted
July 13, 2020
Study Start
March 18, 2019
Primary Completion
October 16, 2019
Study Completion
July 1, 2021
Last Updated
September 9, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
Available by request